Therapeutic Asset Ratings
5,108 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Busulfanum
Chronic Myelomonocytic Leukemia
Center for International Blood and Marrow Transplant Research
P3
BB
(64)
Busulfanum
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
National Cancer Institute (NCI)
P3
BB
(64)
Cabozantinib
Prostate Adenocarcinoma
University of Utah
P3
BB
(64)
Cabozantinib
Nonpapillary Renal Cell Carcinoma
SWOG Cancer Research Network
P3
BB
(64)
Cabozantinib
Sarcomatoid Renal Cell Carcinoma
City of Hope Medical Center
P3
BB
(64)
Calcined Magnesia
Vascular Disorder
Coordinación de Investigación en Salud, Mexico
P3
BB
(64)
Camustine
Non-Hodgkin Lymphoma
VIVUS LLC
P3
BB
(64)
Capecitabine
Gastric Cancer
I-Mab Biopharma US Limited
P3
BB
(64)
Capecitabine
Triple-Negative Breast Carcinoma
National University Hospital, Singapore
P3
BB
(64)
Capivasertib
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.
P3
BB
(64)
Carboplatin
Anal Squamous Cell Carcinoma
Fudan University
P3
BB
(64)
Carboplatin
Hepatoblastoma
Children's Oncology Group
P3
BB
(64)
Carboplatin
Melanoma
Rapa Therapeutics LLC
P3
BB
(64)
Carboplatin
Neoplasm
Bristol-Myers Squibb
P3
BB
(64)
Carboplatin
Nervous System Neoplasm
Blueprint Medicines Corporation
P3
BB
(64)
Carboplatin
Radiation Injury
Sun Yat-sen University
P3
BB
(64)
Carboplatin
Small Cell Carcinoma
SystImmune Inc.
P3
BB
(64)
Carisbamate
Lennox-Gastaut Syndrome
SK Life Science, Inc.
P3
BB
(64)
Carvedilol
Heart Disorder
Abramson Cancer Center at Penn Medicine
P3
BB
(64)
Cediranib
Fallopian Tube Clear Cell Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(64)
Cediranib
Ovarian Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P3
BB
(64)
Cediranib
Ovarian Carcinoma
National Cancer Institute (NCI)
P3
BB
(64)
Cediranib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P3
BB
(64)
Cenobamate
Generalized Epilepsy
Ono Pharmaceutical Co., Ltd.
P3
BB
(64)
Cetuximab
Colorectal Carcinoma
Shanghai Changzheng Hospital
P3
BB
(64)
Showing 1626 to 1650 of 5,108 assets
Previous
Page 66 of 205
Next